Időskori makuladegeneráció trials, also abroad
220 open Időskori makuladegeneráció trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Egyesült Államok | 95 |
| Kína | 38 |
| Franciaország | 27 |
| Olaszország | 26 |
| Németország | 22 |
| All other countries |
The same trial often runs in several countries
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) has 5 sites in Ausztria and runs in 18 countries. If a site near you is full, another one may still take people.
See Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) in all 18 countries